| Jan'20 | Oct'19 | Jul'19 | Apr'19 | Jan'19 | Oct'18 | Jul'18 | Apr'18 | Jan'18 | Jul'17 |
|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
CURRENT ASSETS | |||||||||
Cash and cash equivalents | |||||||||
9,522 | 10,771 | 12,024 | 12,969 | 14,769 | 10,086 | 15,803 | 10,605 | 12,008 | 11,756 |
Trade accounts receivable, net of allowance for doubtful accounts of $170 and $122 at January 31, 2020 and July 31, 2019, respectively | |||||||||
325 | 229 | 450 | 672 | 356 | 379 | 287 | 406 | 226 | 264 |
Due from Rafael Pharmaceuticals | |||||||||
118 | 120 | 280 | - | - | - | - | - | - | - |
Marketable securities | |||||||||
- | - | - | - | - | 20,061 | 24,701 | 30,942 | - | 0 |
Due from Rafael Pharmaceuticals | |||||||||
- | - | - | 160 | - | 3,435 | 3,300 | 1,600 | - | 0 |
Prepaid expenses and other current assets | |||||||||
326 | 540 | 507 | 840 | 588 | 484 | 421 | 645 | 191 | 147 |
Total current assets | |||||||||
10,291 | 11,660 | 13,261 | 14,641 | 15,713 | 34,445 | 44,512 | 44,198 | 12,425 | 12,167 |
Property and equipment, net | |||||||||
48,250 | 48,588 | 48,733 | 49,181 | 49,378 | 49,740 | 50,113 | 50,554 | 50,967 | 51,160 |
Investments - Rafael Pharmaceuticals | |||||||||
70,018 | 70,018 | 70,018 | 70,018 | 70,018 | 23,300 | 13,300 | 11,700 | 11,700 | 11,700 |
Investments - Other Pharmaceuticals | |||||||||
2,000 | 2,000 | 2,000 | - | - | - | - | - | - | - |
Investments - Other Pharmaceuticals | |||||||||
- | - | - | 2,000 | 2,000 | 2,000 | 2,000 | 5,949 | - | 1,778 |
Investments - Hedge Funds | |||||||||
5,645 | 5,088 | 5,125 | 4,632 | 4,166 | 4,314 | 4,218 | - | - | 0 |
Deferred income tax assets, net | |||||||||
7 | 20 | 19 | 24 | 15 | 40 | - | 8 | 22 | 8,859 |
Patents | |||||||||
- | - | - | 407 | 324 | 324 | - | 180 | 155 | 0 |
In-process research and development and patents | |||||||||
1,575 | 1,575 | 1,575 | 1,327 | 1,327 | 1,327 | 1,651 | 1,575 | 1,588 | 0 |
Other assets | |||||||||
1,450 | 1,451 | 1,412 | 1,223 | 1,225 | 1,139 | 1,126 | 920 | 787 | 540 |
TOTAL ASSETS | |||||||||
139,236 | 140,400 | 142,143 | 143,453 | 144,166 | 116,629 | 116,920 | 115,084 | 77,644 | 86,204 |
LIABILITIES AND EQUITY | |||||||||
CURRENT LIABILITIES | |||||||||
Trade accounts payable | |||||||||
569 | 621 | 795 | 755 | 535 | 298 | 367 | 362 | 89 | 115 |
Accrued expenses | |||||||||
579 | 564 | 605 | 203 | 650 | 431 | 500 | 296 | 423 | 213 |
Other current liabilities | |||||||||
48 | 15 | 27 | 19 | 20 | 18 | 24 | 27 | 20 | 35 |
Total current liabilities | |||||||||
1,196 | 1,200 | 1,427 | 977 | 1,205 | 747 | 891 | 685 | 532 | 363 |
Due to Related Party | |||||||||
29 | 28 | 65 | 44 | - | 582 | 276 | -621 | 24,391 | 23,693 |
Convertible note, net of discount of $0 and $54 - Related Party | |||||||||
- | - | 14,946 | 14,940 | 14,934 | - | - | - | - | - |
Other liabilities | |||||||||
92 | 210 | 292 | 210 | 195 | 174 | 188 | 70 | 95 | 70 |
Accrued interest on convertible note - Related Party | |||||||||
- | - | 649 | 418 | - | - | - | - | - | - |
TOTAL LIABILITIES | |||||||||
1,317 | 1,438 | 17,379 | 16,589 | 16,334 | 1,503 | 1,355 | 134 | 25,018 | 24,126 |
COMMITMENTS AND CONTINGENCIES | |||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 |
EQUITY | |||||||||
Group equity | |||||||||
- | - | - | - | - | - | - | 0 | - | 50,427 |
Common stock value | |||||||||
- | - | - | - | - | - | - | - | 40,554 | - |
Additional paid-in capital | |||||||||
128,843 | 128,642 | 112,898 | 117,383 | 117,269 | 103,784 | 103,636 | 103,509 | - | 0 |
Accumulated deficit | |||||||||
-8,691 | -7,438 | -5,840 | -3,654 | -2,649 | -1,628 | -1,108 | -192 | - | 0 |
Accumulated other comprehensive income related to foreign currency translation adjustment | |||||||||
3,756 | 3,790 | 3,784 | 4,134 | 4,080 | 4,160 | 4,043 | 1,998 | 2,394 | 2,316 |
Total equity attributable to Rafael Holdings, Inc. | |||||||||
124,065 | 125,151 | 110,981 | 118,002 | 118,827 | 106,442 | 106,697 | 105,441 | 42,948 | 52,743 |
Noncontrolling interests | |||||||||
13,854 | 13,811 | 13,783 | 8,862 | 9,005 | 8,684 | 8,868 | 9,509 | 9,678 | 9,335 |
TOTAL EQUITY | |||||||||
137,919 | 138,962 | 124,764 | 126,864 | 127,832 | 115,126 | 115,565 | 114,950 | 52,626 | 62,078 |
TOTAL LIABILITIES AND EQUITY | |||||||||
139,236 | 140,400 | 142,143 | 143,453 | 144,166 | 116,629 | 116,920 | 115,084 | 77,644 | 86,204 |
Common Stock, Series A | |||||||||
Common stock value | |||||||||
8 | 8 | 8 | 8 | 8 | - | 8 | - | - | - |
Total equity attributable to Rafael Holdings, Inc. | |||||||||
- | 8 | - | - | - | - | 8 | - | - | - |
TOTAL EQUITY | |||||||||
8 | 8 | 8 | - | - | - | 8 | - | - | - |
Common Class B | |||||||||
Common stock value | |||||||||
149 | 149 | 131 | 131 | 119 | - | 118 | - | - | - |
TOTAL EQUITY | |||||||||
149 | 149 | 131 | - | - | - | 118 | - | - | - |
Common Stock, Series B | |||||||||
Total equity attributable to Rafael Holdings, Inc. | |||||||||
- | 149 | - | - | - | - | 118 | - | - | - |